ANGELA AMENDOLA: Open Payments
NPI 1447267604 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,142 in 14 payments from 7 companies in 2025. Trend: 2023 $1,873 · 2024 $598 · 2025 $2,142
Consulting: $1,192Food & beverage: $898Travel & lodging: $52
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 4 | $1,368 |
| Medtronic, Inc. | 5 | $324 |
| Insulet Corporation | 1 | $175 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| CeQur Corporation | 1 | $6 |
Products named: TZIELD, MINIMED 780G, Omnipod, PREVYMIS, FARXIGA, MYCARELINK, GVOKE HYPOPEN, CeQur Simplicity.
Industry payments across NY — which companies pay providers there.
